Search results
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC News via Yahoo News· 2 minutes agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 23 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life Style via AOL· 1 hour agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
COVID cases rising in L.A. County and California as new subvariants make mark
Los Angeles Times· 1 day agoCalifornia’s COVID numbers are on the rise thanks, in part, to new subvariants, suggesting an...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 3 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 5 hours agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Vaccine critics misrepresent US appeals court ruling over Covid-19 shots
AFP via Yahoo News· 2 days agoVaccine skeptics are claiming a US federal appeals court ruled in June 2024 that Covid-19 shots are...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 3 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Moderna’s next-gen COVID vaccine shows non-inferiority to its current shot
WSAU Wausau· 10 hours ago(Reuters) -Moderna said on Thursday its next-generation COVID-19 vaccine candidate met its main goal...